Predictmedix AI Inc C.PMED

Alternate Symbol(s): PMEDF

Predictmedix AI Inc. is a Canada-based provider of rapid health screening and remote patient care solutions globally. The Company’s Safe Entry Stations, powered by artificial intelligence AI, use multispectral cameras to analyze physiological data patterns and predict a variety of health issues, including infectious diseases, such as COVID-19, impairment by drugs or alcohol, fatigue, or various mental illnesses. Its remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. Its solutions include Infectious Disease Screening, Impairment Screening, and Mobilewellbeing. The Infectious Disease Screening screen for COVID-19, its variants, and other infectious diseases. It offers cannabis and alcohol impairment screening. Mobilewellbeing is a software platform with patient monitoring devices. The Company’s autonomous, non-invasive, no-contact solutions detect symptoms before they spread through workplace.

CSE:PMED - Post by User

Predictmedix AI Inc

<< Previous

Bullboard Posts

Next >>

Post by Respuns7saon Feb 22, 2021 2:36pm

131 Views

Post# 32628170

Picking Interest

Sponsored Post: Consumers could have spent approximately $28 billion on anti-depressants in 2019. This could show a part of how huge the need of being able to produce something that could benefit people who struggle in depression. But, how could cannabis take part on the revolutionary take on this one?

Global beverage market could move from approximately $89 million to approximately $1.4 billion within the next two years! This could be a good way to infuse cannabis in consummables. This could also pick such interest for consumers and direct to consumer market.

Check the disclaimer on profile and the landing page.

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver